Effects of ertiprotafib on hepatic cytochrome P450 and peroxisomal enzymes in rats and dogs, and in rat and human primary hepatocytes

References

• Aitio A, Vainio H. UDP glucronosyltransferase and mixed function oxidase activity in microsomes prepared by differential centrifugation and calcium aggregation. Acta Pharmacologica et Toxicologica 1976; 39: 555–561
   PubMedGoogle Scholar
• Arlotto MP, Greenway DJ, Parkinson A. Purification of two isozymes of rat liver microsomal cytochrome P450 with testosterone 7α-hydroxylase activity. Archives in Biochemistry and Biophysics 1988; 270: 441–457
   Google Scholar
• Barter RA, Klaassen CD. UDP-glucuronosyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism. Toxicology and Applied Pharmacology 1992; 113: 36–42
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Annals of Biochemistry 1976; 72: 248–254
   Web of Science ®Google Scholar
• Burke MD, Mayer RT. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chemico-Biological Interactions 1983; 45: 243–258
   PubMed Web of Science ®Google Scholar
• Byon JCH, Kusari AB, Kusari J. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Molecular Cell Biochemistry 1998; 182: 101–108
   PubMed Web of Science ®Google Scholar
• Catania VA, Luquita MG, Carrillo MC, Mottino AD. Sex differences in spironolactone induction of rat intestinal and hepatic p-nitrophenol UDP-glucuronosyltransferase. Canadian Journal of Physiology and Pharmacology 1990; 68: 1385–1387
   PubMedGoogle Scholar
• Corton JC, Lapinskas PJ, Gonzalez FZ. Central role of PPARa in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutation Research and Fundamental Molecular Mechanisms in Mutagenesis 2000; 448: 139–151
   PubMed Web of Science ®Google Scholar
• Doull J, Cattley R, Elcombe C, Lake BG, Swenberg J, Wilkinson C, Williams G, Gemert M. A cancer risk assessment of di(2-ethylhexyl)phthalate: Application of the new U.S. EPA risk assessment guidelines. Regulatory Toxicology and Pharmacology 1999; 29: 327–357
   PubMed Web of Science ®Google Scholar
• Ducrotoy G, Richert L, De Sandro V, Lurier D, Pacaud E. Determination of 125I-labelled thyroxine glucuronide by reversed-phase high-performance liquid chromatography using on-line radiochemical detection to determine UDPglucuronosyltransferase activity. Journal of Chromatography 1991; 566: 415–426
   PubMedGoogle Scholar
• Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein-tyrosine phosphatase-1B gene. Science 1999; 283: 1544–1548
   PubMed Web of Science ®Google Scholar
• Erbe D, Wang S, Zhang Y, Harding K, Kung L, Tam M, Stolz L, Xing Y, Furey S, Qadri A, et al. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. Molecular Pharmacology 2005; 67: 69–77
   PubMed Web of Science ®Google Scholar
• Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG. The non-transmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 1992; 68: 545–560
   PubMed Web of Science ®Google Scholar
• Goldstein BJ. Protein-tyrosine phosphatases and the regulation of insulin action. Journal of Cell Biochemistry 1992; 48: 33–42
   PubMed Web of Science ®Google Scholar
• Goldstein BJ. Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation. Receptor 1993; 3: 1–15
   PubMedGoogle Scholar
• Gray TJ, Beamand JA, Lake BG, Foster JR, Gangolli SD. Peroxisome proliferation in cultured rat hepatocytes produced by clofibrate and phthalate ester metabolites. Toxicology Letters 1982; 10: 273–279
   PubMed Web of Science ®Google Scholar
• Gray TJ, Lake BG, Beamand JA, Foster JR, Gangolli SD. Peroxisome proliferation in primary cultures of rat hepatocytes. Toxicology and Applied Pharmacology 1983; 67: 15–25
   PubMed Web of Science ®Google Scholar
• Hardwick JP, Song BJ, Huberman E, Gonzalez FJ. Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family. Journal of Biology and Chemistry 1987; 262: 801–810
   PubMed Web of Science ®Google Scholar
• Hertz R, Bar-Tana J. Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans. Toxicology Letters 1998; 102–103: 85–90
   PubMedGoogle Scholar
• Hill RN, Erdreich LS, Paytner OE, Roberts PA, Rosenthal SL, Wilkinson CF. Thyroid-follicular cell carcinogenesis. Fundamentals of Applied Toxicology 1989; 12: 629–697
   PubMedGoogle Scholar
• Hood AM, Hashmi R, Klaassen CD. Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrpphy. Toxicology and Applied Pharmacology 1999; 160: 163–170
   PubMed Web of Science ®Google Scholar
• Hood AM, Klaassen CD. Differential effects of microsomal enzyme inducers on in vitro thyroxine (T4) and triiodothyronine (T3) glucuronidation. Toxicological Sciences 2000; 55: 78–84
   PubMed Web of Science ®Google Scholar
• Issemann I, Green S. Activation of a number of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645–650
   PubMed Web of Science ®Google Scholar
• Johnson EF, Palmer CN, J GK, Hsu MH. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB Journal 1996; 10: 1241–1248
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Uy-Yu N, Kozuka H. Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver. Biochemistry Journal 1989; 261: 595–600
   PubMed Web of Science ®Google Scholar
• Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Molecular Cell Biology 2000; 20: 5479–5489
   PubMed Web of Science ®Google Scholar
• Krey G, Braissant O, L’Horset F, Kalkhoven E, Perroud M, Parker MG, Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Molecular Endocrinology 1997; 11: 779–791
   PubMed Web of Science ®Google Scholar
• Kroetz DL, Yook P, Costet P, Bianchi P, Pineau T. Peroxisome proliferator-activated receptor α controls the hepatic CYP4A induction adaptive response to starvation and diabetes. Journal of Biology and Chemistry 1998; 273: 31581–31589
   PubMed Web of Science ®Google Scholar
• Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Molecular Cell Biology 1995; 15: 3012–3022
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Barter RA, Klaassen CD. Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: A dose–response study. Journal of Pharmacology and Experimental Therapy 1995; 273: 977–985
   PubMed Web of Science ®Google Scholar
• Makowska JM, Anders C, Goldfarb PS, Bonner F, Gibson GG. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strains. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation. Biochemistry and Pharmacology 1990; 40: 1083–1093
   PubMed Web of Science ®Google Scholar
• Moller DE. New drug targets for type 2 diabetes and teh metabolic syndrome. Nature 2001; 13: 821–827
   Google Scholar
• Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Current Opinions in Cell Biology 1997; 9: 193–204
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. The carbon-monoxide binding pigment of liver microsomes. Journal of Biology and Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Pan J, Xiang Q, Renwick AB, Price RJ, Ball SE, Kao J, Scatina JA, Lake BG. Use of a quantitative real-time reverse transcription-polymerase chain reaction method to study the induction of CYA1A, CYP2B and CYP4A forms in precision-cut rat liver slices. Xenobiotica 2002; 32: 739–747
   PubMed Web of Science ®Google Scholar
• Qi C, Zhu Y, Reddy JK. Peroxisome proliferatior-activated receptors, coactivators, and downstream targets. Cell Biochemistry and Biophysics 2000; 32: 187–204
   PubMed Web of Science ®Google Scholar
• Reddy JK, Krishnakantha TP. Hepatic peroxisome profileration: Induction by two novel compounds structually unrelated to clofibrate. Science 1975; 190: 787–789
   PubMed Web of Science ®Google Scholar
• Reddy JK, Kumar NS. Stimulation of catalase synthesis and increase of carnitine acetyltransferase activity in the liver of intact female rats fed clofibrate. Journal of Biochemistry 1979; 85: 847–856
   PubMed Web of Science ®Google Scholar
• Rodrigues AD, Machinist JM. Hepatic peroxisomal and drug metabolizing activity in CD-1 mice after oral treatment with a novel 5-lipoxygenase inhibitor. Toxicology and Applied Pharmacology 1996; 137: 193–201
   PubMedGoogle Scholar
• Sharma R, Lake BG, Foster J, Gibson GG. Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolidaemic agents in rat liver. A mechanistic interrelationship. Biochemistry and Pharmacology 1988; 37: 1193–1201
   PubMed Web of Science ®Google Scholar
• Spiegelman BM. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47: 507–514
   PubMed Web of Science ®Google Scholar
• Sundseth SS, Waxman DJ. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid ω-hydroxylases. Journal of Biology and Chemistry 1992; 267: 3915–3921
   PubMed Web of Science ®Google Scholar
• Temple AR, Done AK, Clement MS. Studies of glucuronidation III. The measurement of p-nitrophenyl glucuronide. Journal of Laboratory and Clinical Medicine 1971; 77: 1015–1019
   PubMedGoogle Scholar
• Vansell NR, Klaassen CD. Effect of microsomal enzyme inducers on the biliary excretion of triiodothyronine (T3) and its metabolites. Toxicological Sciences 2002; 65: 184–191
   PubMed Web of Science ®Google Scholar